Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
|ClinicalTrials.gov Identifier: NCT00791440|
Recruitment Status : Completed
First Posted : November 14, 2008
Last Update Posted : December 13, 2012
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia Schizoaffective Disorder Schizophreniform Disorder||Behavioral: Cognitive-Behavior Therapy Other: Standard Psychiatric Treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||34 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Psychosis in Schizophrenia: Mechanisms of Recovery|
|Study Start Date :||November 2008|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||June 2012|
Up to 26 sessions (over a 30 week period) of weekly, individual Cognitive-Behavior Therapy (CBT) to target hallucinations and delusions in addition to standard psychiatric treatment.
Behavioral: Cognitive-Behavior Therapy
Weekly individual Cognitive-Behavior Therapy (CBT) to target hallucinations and delusions in addition to standard psychiatric treatment.
Other Name: CBT for psychosis
Active Comparator: 2
30 weeks of standard psychiatric treatment.
Other: Standard Psychiatric Treatment
Standard psychiatric treatment.
Other Name: Treatment As Usual (TAU)
- Scale for the Assessment of Positive Symptoms (SAPS) [ Time Frame: At Baseline and after 10, 20 and 30 weeks ]
- Momentary self-report ratings of psychotic symptoms using a Palm computer [ Time Frame: At Baseline and after 30 weeks ]
- Momentary self-report ratings of stress and coping strategies using a Palm computer [ Time Frame: at Baseline and after 30 weeks ]
- Momentary ambulatory measures of heart rate and breathing [ Time Frame: At Baseline and after 30 weeks ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00791440
|United States, New York|
|Columbia University & New York State Psyciatric Institute|
|New York, New York, United States, 10032|
|Principal Investigator:||David Kimhy, Ph.D.||Columbia University & New York State Psyciatric Institute|